Почетна › Миастенија гравис › Тексас
Kliničke studije za Миастенија гравис u državi Тексас
16 studija za Миастенија гравис traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
Zvanični tekst studije (na engleskom)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1003, Dallas
- Site Number - 1047, Denton
- Site Number - 1057, Houston
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07039916ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- National Neuromuscular Research Institute, Austin
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07673627Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Austin Neuromuscular Center, Austin
- Texas Neurology, Dallas
- The University of Texas Health Science Center at Houston, Houston
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Cinical Study Site, Houston
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 30. 10. 2026. · NCT07647510ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- National Neuromuscular Research Institute, Austin
- University of Texas- San Antonio - Health Science Center - PPDS, San Antonio
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07294170A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Austin Neuromuscular Center, Austin
Тражи се учесникФаза 2
Узраст од 2 до 17 · Оба пола · Ажурирано 23. 10. 2026. · NCT06987539Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
- UT Southwestern Medical Center, Dallas
- Houston Methodist Hospital, Houston
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06626919Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Baylor Scott & White Research Institute - Baylor Scott & White Research Institute, Dallas
- ANESC Research, El Paso
- Baylor Scott & White Neurology - McKinney, McKinney
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06463587RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Baylor College of Medicine Neurology Department, Houston
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
Тражи се учесникФаза 1/2
Узраст од 18 до 70 · Оба пола · Ажурирано 19. 10. 2026. · NCT06359041ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- National Neuromuscular Research Institute, Austin
- University of Texas- San Antonio - Health Science Center - PPDS, San Antonio
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT07284420Study of Aritinercept in Patients With Generalized Myasthenia Gravis
- Aurinia Investigational Site, Houston
Тражи се учесникФаза 1/2
Узраст од 18 до 85 · Оба пола · Ажурирано 3. 8. 2026. · NCT07596901KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Houston Methodist Hospital, Houston
Тражи се учесникФаза 2/3
Узраст од 18 до 75 · Оба пола · Ажурирано 29. 7. 2026. · NCT06193889Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 18. 2. 2026. · NCT04202341A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- National Neuromuscular Research Institute, Austin
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 17. 2. 2026. · NCT06298565A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
- Nerve & Muscle Center of Texas, Houston
- Houston Methodist Neurological Institute, Houston
Тражи се учесникФаза 1/2
Узраст од 18 до 74 · Оба пола · Ажурирано 11. 2. 2026. · NCT07250750Vitaccess Real MG Registry
- University of Texas Health Science Center at Houston, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 29. 7. 2025. · NCT06064461Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.